These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36416227)

  • 1. Racial differences in positive findings on embedded performance validity tests.
    Hromas G; Rolin S; Davis JJ
    Appl Neuropsychol Adult; 2022 Nov; ():1-9. PubMed ID: 36416227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance validity in the dementia clinic: Specificity of validity tests when used individually and in aggregate across levels of cognitive impairment severity.
    Martin PK; Schroeder RW; Olsen DH
    Clin Neuropsychol; 2022 Jan; 36(1):165-188. PubMed ID: 32552601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered.
    Davis JJ
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1013-1021. PubMed ID: 29779432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance validity in undergraduate research participants: a comparison of failure rates across tests and cutoffs.
    An KY; Kaploun K; Erdodi LA; Abeare CA
    Clin Neuropsychol; 2017 Jan; 31(1):193-206. PubMed ID: 27687709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 7. Demographic differences in performance validity test failure.
    Braun SE; Fountain-Zaragoza S; Halliday CA; Horner MD
    Appl Neuropsychol Adult; 2023; 30(5):483-491. PubMed ID: 34428386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of Embedded Performance Validity Tests in Elderly Veterans with Mild and Major Neurocognitive Disorder.
    Kanser RJ; Logan PM; Steward KA; Vanderbleek EN; Kamper JE
    Arch Clin Neuropsychol; 2023 Jul; 38(5):772-781. PubMed ID: 36578198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there differences in performance validity test scores between African American and White American neuropsychology clinic patients?
    D Hood E; B Boone K; S Miora D; E Cottingham M; L Victor T; A Zeigler E; A Zeller M; J Wright M
    J Clin Exp Neuropsychol; 2022 Feb; 44(1):31-41. PubMed ID: 35670549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of Abnormally Low TOPF Word Reading Scores in Individuals Failing Versus Passing Performance Validity Testing.
    Martin PK; Schroeder RW; Wyman-Chick KA; Hunter BP; Heinrichs RJ; Baade LE
    Assessment; 2018 Jul; 25(5):640-652. PubMed ID: 27364003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Direct Comparison of 10 WAIS-IV Digit Span Embedded Validity Indicators among a Mixed Neuropsychiatric Sample with Varying Degrees of Cognitive Impairment.
    Resch ZJ; Cerny BM; Ovsiew GP; Jennette KJ; Bing-Canar H; Rhoads T; Soble JR
    Arch Clin Neuropsychol; 2023 May; 38(4):619-632. PubMed ID: 36244241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of New Embedded Performance Validity Indicators for the Child and Adolescent Memory Profile (ChAMP) Objects Subtest in Youth with Mild Traumatic Brain Injury.
    Brooks BL; MacAllister WS; Fay-McClymont TB; Vasserman M; Sherman EMS
    Arch Clin Neuropsychol; 2019 Jun; 34(4):531-538. PubMed ID: 30124740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of differential neurocognitive performance based on the number of performance validity tests failures: A cross-validation study across multiple mixed clinical samples.
    Jennette KJ; Williams CP; Resch ZJ; Ovsiew GP; Durkin NM; O'Rourke JJF; Marceaux JC; Critchfield EA; Soble JR
    Clin Neuropsychol; 2022 Oct; 36(7):1915-1932. PubMed ID: 33759699
    [No Abstract]   [Full Text] [Related]  

  • 17. Examination of performance validity test failure in relation to number of tests administered.
    Davis JJ; Millis SR
    Clin Neuropsychol; 2014; 28(2):199-214. PubMed ID: 24528190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.